Hartsuyker, Patrick, Kanczuk, Marcelo E., Lawn, David, Beg, Salwa, Mengistu, Tesfaye S., and Hiskens, Matthew (2023) The effect of class 3 obesity on the functionality of supraglottic airway devices: a historical cohort analysis with propensity score matching. Canadian Journal of Anaesthesia, 70 (11). pp. 1744-1752.

PDF (Published Version) - Published Version Restricted to Repository staff only

 

1

1

Abstract

Purpose: Supraglottic airway devices (SGAs) have been increasingly used as a primary airway in patients undergoing anesthesia as an alternative to endotracheal tubes. Second-generation devices have expanded their applicability to include uses in patients with obesity. Nevertheless, there is limited evidence of SGA suitability for patients with class 3 obesity (body mass index [BMI] ≥ 40 kg·m–2). As such, we compared rates of SGA functionality between patients with class 3 obesity and patients without class 3 obesity undergoing general anesthesia.

Methods: We performed a propensity score matching analysis using inverse probability of treatment weighting to compare the functionality of SGAs in adult patients with class 3 obesity vs without class 3 obesity. These patients underwent surgery at a hospital in Queensland, Australia from November 2017 to September 2020 and had a SGA inserted as part of their anesthetic care. All data were collected from patients’ electronic medical records. We included 321 patients in the cohort with class 3 obesity and 471 in the cohort without class 3 obesity (control/comparison). The estimated effect of class 3 obesity on SGAs was calculated using adjusted odds ratios (AORs) with their 95% confidence intervals (CIs).

Results: The overall weighted prevalence of nonfunctional SGAs was 3.2%, with a significantly higher rate in the class 3 obesity cohort compared with the control cohort (4.7% vs 2.1%) (P = 0.04). This adjusted analysis illustrates that class 3 obesity was associated with an almost four times higher odds of a nonfunctional SGA (odds ratio [OR], 2.3; 95% CI, 1.0 to 5.1; AOR, 3.9; 95% CI, 1.4 to 10.6) than patients without class 3 obesity.

Conclusion: Patients with class 3 obesity (BMI ≥ 40 kg·m–2) had greater than three-fold odds of nonfunctional intraoperative SGAs than patients without class 3 obesity.

Actions (Repository Staff Only)

Item Control Page